Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,316 | 0,338 | 23.12. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
SPECTRAL MEDICAL Aktie jetzt für 0€ handeln | |||||
Di | Spectral Medical (TSE:EDT) Share Price Passes Below Fifty Day Moving Average - Here's What Happened | 1 | MarketBeat | ||
03.12. | Spectral Medical Inc: Spectral sees low patient enrolment for Tigris trial | 1 | Stockwatch | ||
02.12. | Spectral Medical Inc.: Spectral Medical Provides November Tigris Trial Update | 72 | GlobeNewswire (Europe) | • 136 patients enrolled • Company to host Tigris Trial Update Call December 16, 2024 TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a... ► Artikel lesen | |
08.11. | Spectral Medical Inc.: Spectral Medical Announces Third Quarter Results and Provides Corporate Update | 206 | GlobeNewswire (Europe) | Tigris Trial Enrollment at 135 PatientsStrengthened Balance Sheet with Expected Funds to Complete Tigris Trial Enrollment TORONTO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral"... ► Artikel lesen | |
04.11. | Spectral Medical Inc: Spectral provides update on Tigris trial | 2 | Stockwatch | ||
04.11. | Spectral Medical Inc.: Spectral Medical Provides October Tigris Trial Update | 1 | GlobeNewswire (USA) | ||
03.10. | Spectral Medical Inc: Spectral enrolls 132 patients in Tigris trial | 1 | Stockwatch | ||
03.09. | Spectral Medical Inc: Spectral enrolls 48 patients in Tigris trial YTD | 1 | Stockwatch | ||
03.09. | Spectral Medical Inc.: Spectral Medical Provides August Tigris Trial Update | 1 | GlobeNewswire (USA) | ||
09.08. | Spectral Medical reports Q2 results | 1 | Seeking Alpha | ||
09.08. | Spectral Medical Inc.: Spectral Medical Announces Second Quarter Results and Provides Corporate Update | 387 | GlobeNewswire (Europe) | Tigris Trial Enrollment Reaches 126 Patients Strengthened Balance Sheet with Expected Funds to Complete Tigris Trial Enrollment TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
01.08. | Spectral Medical Inc: Spectral has 125 patients enrolled in Tigris trial | 1 | Stockwatch | ||
01.08. | Spectral Medical Inc.: Spectral Medical Provides July Tigris Trial Update | 1 | GlobeNewswire (USA) | ||
22.07. | Spectral Medical Inc: Spectral Medical closes $1-million (U.S.) note offering | 1 | Stockwatch | ||
11.07. | Spectral Medical Inc: Spectral Medical changes auditor to MNP | 1 | Stockwatch | ||
11.07. | Spectral Medical Inc. Announces Change to Auditor | 1 | GlobeNewswire (USA) | ||
02.07. | Spectral Medical Inc: Spectral enrolls nine patients in Tigris trial in June | 1 | Stockwatch | ||
02.07. | Spectral Medical Inc.: Spectral Medical Provides June Tigris Trial Update | 203 | GlobeNewswire (Europe) | 116 patients enrolledJune represents a new record breaking month for patient enrollment TORONTO, July 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT)... ► Artikel lesen | |
07.06. | Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders | 293 | GlobeNewswire (Europe) | TORONTO, June 07, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock... ► Artikel lesen | |
13.05. | Spectral Medical Inc.: Spectral Medical Announces First Quarter Results and Provides Corporate Update | 264 | GlobeNewswire (Europe) | Tigris Trial Enrollment Reaches 106 Patients Bought Deal Financing Expected to Fund Completion of Tigris Trial Enrollment TORONTO, May 13, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral"... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS MEDICAL CARE | 43,550 | -0,75 % | INDEX-MONITOR: Covestro fällt mit Übernahme aus dem Dax - FMC folgt | FRANKFURT/ZUG (dpa-AFX) - Der vor der Übernahme stehende Kunststoffkonzern Covestro fliegt zwischen Weihnachten und Neujahr aus dem deutschen Aktienleitindex Dax . Grund für die außerplanmäßige Änderung... ► Artikel lesen | |
RHOEN-KLINIKUM | 13,900 | +0,72 % | Erfolgreicher Einsatz des RISE Highspeed-Konnektors in der Produktivumgebung der RHÖN-KLINIKUM AG | Schwechat/Berlin (ots) - Betrieb des RISE Highspeed-Konnektors in der Produktivumgebung zeigt bereits deutliche Verbesserungen im KrankenhausalltagNach der Zulassung des RISE Highspeed-Konnektors durch... ► Artikel lesen | |
ROKU | 75,73 | +0,03 % | Roku (NASDAQ:ROKU) Trading 1% Higher - Time to Buy? | ||
SERNOVA | 0,143 | -3,19 % | Sernova Corp.: Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025 | ||
VITA 34 | 4,100 | -0,49 % | Original-Research: Vita 34 AG (von Montega AG): Vita 34 AG | Original-Research: Vita 34 AG - von Montega AG 27.11.2024 / 10:10 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group AG. Für den Inhalt der Mitteilung... ► Artikel lesen | |
M1 KLINIKEN | 16,250 | +3,17 % | Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: M1 Kliniken AG - from First Berlin Equity Research GmbH 17.12.2024 / 12:00 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. The issuer... ► Artikel lesen | |
GERATHERM MEDICAL | 3,660 | +5,78 % | Geratherm Medical Aktie: Keine Überraschungen erwartet | Die Geratherm Medical AG verzeichnete in den vergangenen Tagen einen beachtlichen Kursanstieg von 28 Prozent. Der aktuelle Aktienkurs liegt bei 3,79 EUR (Stand: 14. Dezember 2024). Diese Entwicklung... ► Artikel lesen | |
PLUS THERAPEUTICS | 1,050 | +13,51 % | Plus Therapeutics Announces Renewal Of Master Services Agreement With Telix | CANBERA (dpa-AFX) - Plus Therapeutics (PSTV) announced the renewal of its Master Services Agreement with Telix IsoTherapeutics Group. The MSA secures supply of cGMP Re-186, the radioisotope... ► Artikel lesen | |
BAXTER | 27,795 | -0,87 % | Baxter-Aktie gewinnt 1,07 Prozent (28,1880 €) | An der US-amerikanischen Börse notiert die Baxter-Aktie aktuell ein wenig fester. Die Aktie notiert gegenwärtig bei 29,22 US-Dollar. Die Aktie von Baxter verzeichnet derzeit ein Kursplus von 1,07 Prozent.... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,950 | -1,66 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Full Results from Phase 2 KARISMA-Endoxifen Study Demonstrating Statistically Significant Reductions in Mammographic Breast Density | 1 MG Dose (Z)-Endoxifen Shows Potential as a Well-Tolerated, Preventative Therapy for Premenopausal Women at Risk of Developing Breast Cancer Data to be Presented in a Poster Spotlight Session During... ► Artikel lesen |